NextCell publishes its Interim Report 3 2022/2023
NextCell Pharma AB (publ) (NXTCL or NextCell) publishes its Interim Report 3 for the period March 1, 2023 – May 31, 2023 The report is available on the company’s website: https://www.nextcellpharma.com/en/investors#financial-report. NextCells share is traded on Nasdaq First North Growth Market under the ticker "NXTCL". The amount in brackets refers to the corresponding period in the previous year.Third quarter (2023-03-01 until 2023-05-31) · Operating income amounted to 4,190 (1,636) TSEK, of which Cellaviva counted for 3,039 (1,613) TSEK. · Operating result amounted to -10,915 (-